PRKN and glioblastoma: The TCGA database showed that a quarter of patients affected by glioblastoma exhibited a partial or total loss of PARK2 (gene encoding for Parkin) [85] but has also demonstrated that silencing of Parkin can be related to the arrest in tumor growth through the cooperation with the Notch signaling pathway [86].